Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q3 2020 · 10-Q
Revenue$0.00$0.00— vs Q3 2019 Net Income-$3.50M-$3.50MN/M vs Q3 2019 EPS Diluted-$0.69-$0.69N/M vs Q3 2019 Operating Income-$3,364,607N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end